Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Treat to target (T2T) is a strategy of adjusting treatment until a target is reached. An international task force recommended T2T for juvenile idiopathic arthritis (JIA) treatment. Implementing T2T in a standard and reliable way in clinical practice requires agreement on critical elements of (1) target setting, (2) T2T strategy, (3) identifying barriers to implementation, and (4) patient eligibility. A consensus conference was held among Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) stakeholders to inform a statement of understanding regarding the PR-COIN approach to T2T.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Rheumatol

Title: The Journal of rheumatology

Publisher: The Journal of Rheumatology

ISSN (Electronic): 1499-2752

ISSN (Print): 0315-162X

Publication date (Electronic): May 2022

Volume: 49

Issue: 5

Affiliations

[1 ] T. El Tal, MD, B.M. Feldman, MD, PhD, R.M. Laxer, MD, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada.

[2 ] M.E. Ryan, DO, D. Bullock, MD, University of Minnesota, Minneapolis, Minnesota, USA.

[3 ] C.A. Bingham, MD, Penn State Children's Hospital, Hershey, Pennsylvania, USA.

[4 ] J.M. Burnham, MD, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

[5 ] M. Batthish, MD, McMaster University, Hamilton, Ontario, Canada.

[6 ] M. Gilbert, MD, Medical University of South Carolina, Charleston, South Carolina, USA.

[7 ] M. Gillispie-Taylor, MD, C. Yildirim Toruner, MD, Texas Children's Hospital Baylor College of Medicine, Houston, Texas, USA.

[8 ] B. Gottlieb, MD, Cohen Children's Medical Center, Lake Success, New York, USA.

[9 ] J.G. Harris, MD, Children's Mercy Kansas City, Kansas City, Kansas, USA.

[10 ] M. Hazen, MD, Boston Children's Hospital, Boston, Massachusetts, USA.

[11 ] T.C. Lee, MD, Stanford Children's Health, Palo Alto, California, USA.

[12 ] D. Lovell, MD, J. Taylor, CNP, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

[13 ] M. Mannion, MD, University of Alabama at Birmingham, Birmingham, Alabama, USA.

[14 ] L. Noonan, MD, Levine Children's Hospital/Carolinas Healthcare System, Charlotte, North Carolina, USA.

[15 ] E. Oberle, MD, Nationwide Children's Hospital, Columbus, Ohio, USA.

[16 ] J.E. Weiss, MD, Hackensack University Medical Center, Hackensack, Hackensack, New Jersey, USA.

[17 ] E.M. Morgan, MD, MSCE, University of Washington, and Seattle Children's Hospital, Seattle, Washington, USA.

Article

Publisher Item ID: jrheum.210709

DOI: 10.3899/jrheum.210709

PubMed ID: 35105705

SO-VID: 67f9316b-1d5a-4831-a579-f9d60416a172

History

Keywords: disease activity score,registries,practice guidelines,physician practice patterns,outcomes,juvenile idiopathic arthritis

Data availability:

Keywords: disease activity score, registries, practice guidelines, physician practice patterns, outcomes, juvenile idiopathic arthritis

Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.

Read this article at

Abstract

Related collections

Serotonin and BEYOND

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 138

Cited by 5